<DOC>
	<DOCNO>NCT02311608</DOCNO>
	<brief_summary>To observe access Effects safety terlipressin high dose somatostatin/octreotide usual dose somatostatin/octreotide fail achieve hemostasis patient acute variceal bleeding .</brief_summary>
	<brief_title>Effects Terlipressin When Usual Somatostatin Octreotide Dose Fails</brief_title>
	<detailed_description>The prognosis information patient acute variceal bleeding collect , include hemostasis rate , early rebleeding rate , mortality , complication , severity adverse event , economic burden quality life , terlipressin high dose somatostatin/octreotide use salvation patient fail achieve initial hemostasis.The result may help gastroenterologist make decision administer vasoactive medicine suffer acute variceal bleeding .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>Cirrhosis patient admit Emergency Department acute variceal bleed No sign variceal bleed find endoscopy portal hypertensive gastropathy responsible bleeding Patients undergo endoscopy 72h begin acute variceal bleeding Patients hepatorenal syndrome Patients ischemia organic cardiopathy ( include myocardial infarction unstable angina pectoris ) myocardial ischemia indicate ECG past 6 month Patients allergic to/with contraindication vasoactive drug</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>acute variceal hemorrhage</keyword>
	<keyword>terlipressin</keyword>
	<keyword>somatostatin</keyword>
	<keyword>octreotide</keyword>
	<keyword>comparative effectiveness research</keyword>
</DOC>